Ignite Creation Date:
2024-05-05 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00760877
Status:
COMPLETED
Last Update Posted:
2016-11-08
First Post:
2008-09-25
Brief Title:
Nilotinib Versus Standard Imatinib 400600 mg Every Day QD Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase CML-CP Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction RQ-PCR
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CAMN107A2405
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None